Phase I study of transarterial chemoembolization using Cisplatin powder and miriplatin in patients with hepatocellular carcinoma
Phase 1
- Conditions
- hepatocellular carcinoma
- Registration Number
- JPRN-UMIN000010431
- Lead Sponsor
- Southern TOHOKU General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1)History of hypersensitivity reaction 2)Other severe complications, such as uncontrollable diabetes or heart failure, renal insufficiency, liver failure 3)Active another cancer 4)Pregnant or possibility pregnancy or nursing woman 5) Physician judged improper to entry this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method